Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report
Abstract
Episodic syndromes that may be associated with migraine, formerly called migraine equivalence syndrome, represent a spectrum of par - oxysmal disorders with pathophysiological links to migraine. They are recognized as prognostic factors for future migraine attacks, often preceding or accompanying classic migraine phenotypes. 1 Abdominal migraine (AM) is one of the episodic syndromes, defined by recurrent abdominal pain as the core symptom and frequently ac - companied by nausea, vomiting, and pallor, with each episode lasting several hours to several days. With advancing age, AM frequently progresses to a more typical form of migraine. In recent years, tar - geted therapy with calcitonin gene-related peptide (CGRP) recep - tor antagonists has achieved remarkable results in adult migraine; however, its application in pediatric AM remains unreported to date. This article reports a successful case of treating an 8- year-old girl with AM using rimegepant, a CGRP receptor antagonist, aiming to provide new insights for clinical practice. The child's guardian pro - vided written informed consent to authorize the publication of the patient's case and the disclosure of this case information. The patient
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.